Clinical Research Directory
Browse clinical research sites, groups, and studies.
Lemborexant on Perioperative Sleep Quality in Patients With Brain Tumor Undergoing Surgery
Sponsor: Beijing Tiantan Hospital
Summary
This study tests whether lemborexant can improve perioperative sleep quality in people with brain tumor undergoing surgery. Adults with brain tumor scheduled for surgery may join. Participants will be randomly assigned to take lemborexant or a placebo the night before surgery. Researchers will measure sleep quality, anesthesia recovery, pain, postoperative recovery, and other outcomes.
Official title: Effect of Lemborexant on Perioperative Sleep Quality in Patients With Brain Tumor Undergoing Surgery: A Randomized, Double-Blinded, Placebo-Controlled Clinical Trial
Key Details
Gender
All
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
112
Start Date
2026-11-01
Completion Date
2027-12-31
Last Updated
2026-10-29
Healthy Volunteers
No
Interventions
Lemborexant 5 mg
Participants will receive a single oral dose of lemborexant 5 mg tablet on the night before brain tumor surgery.
placebo
Participants will receive a single oral dose of matching placebo tablet on the night before brain tumor surgery.